News
Brain Health Isn’t Seasonal, but Winter Comes with Added Risk
Winter is here, and for millions of Americans, so is a higher risk of head injury. Winter brings more than just cold temperatures.
FOX19 Highlights Sense Neuro Diagnostics’ Initiatives in Rapid Brain Injury Detection
Sense Neuro Diagnostics was recently featured by FOX19 in a segment with one of our co-founders, Dr. George “Chip” Shaw. Dr. Shaw discussed our ongoing efforts to support faster and more accurate brain injury assessment in emergency care.
Sense Neuro Diagnostics Submits FDA Application for NeuroHawk, A Breakthrough in Rapid Stroke and TBI Detection
Sense Neuro Diagnostics, a leader in non-invasive neurodiagnostic technology, announced today that it has formally submitted its NeuroHawk™ system to the U.S. Food and Drug Administration (FDA) for regulatory clearance.
Sense Neuro Diagnostics appoints Gary Kurdziel as Chief Executive Officer
Sense Diagnostics, Inc. announced that its board of directors has appointed Gary Kurdziel as Chief Executive Officer, effective April 1, 2025.
Our CEO Geoffrey Klass will be presenting at NeuroTech at CES in Las Vegas
This is an exciting opportunity to share how Sense Diagnostics is revolutionizing brain scans with innovative technology designed to deliver faster, more accurate insights.
Gary Kurdziel Joins Sense Neuro Diagnostics as Executive Vice President, Chief Commercial Officer
Gary Kurdziel Joins Sense Neuro Diagnostics as Executive Vice President, Chief Commercial OfficerCincinnati, OH - Sense Neuro Diagnostics is thrilled to announce the appointment of Gary Kurdziel as Executive Vice President, Chief Commercial Officer. With an...
TRAIL BLAZERS: Cincy Inno's Fire Award Winners Setting the Innovation Scene Aflame
Cincinnati Business Courier
June 23, 2023
Sense Neuro Diagnostics OK'd for new trial, its last as it nears commercialization
Cincinnati Business Courier
May 30, 2023
Sense Neuro Diagnostics lands $250,000 equity investment from St. Elizabeth Healthcare
Cincinnati Business Courier
March 20, 2023
NFL Legend Joins Renowned Professors and Innovators to Tackle Traumatic Brain Injury at LSI USA '23
Yahoo! Finance
March 15, 2023
Introducing the Inno Madness Bracket
March 9, 2023
Sense Neuro adds second office in Phoenix after landing Mayo Clinic agreement
January 25, 2023
Sense Diagnostics inks 'know-how' license agreement with Mayo Clinic
December 14, 2022
These are the Greater Cincinnati startups to watch in 2021
Dec 11, 2020
MedCity INVEST Pitch Perfect Winners
National Healthcare
Investing Event
July 20-24 2020. Virtual Conference.
$1.3 Million Invested In Brain Injury Start-Up
CISION PRWeb
Sep 9, 2019
14 Health-Related Companies That Have Raised More Than $100K
CINCYINNO
Aug 16, 2018
22 NeuroTech Companies That Want to Hack Your Brain
TechAcute.com
Oct 13, 2017
29 Neurotech Companies Interfacing With Your Brain
Nanalyze
Oct 10, 2017
Kincaid 2 Of 2 Brain Monitor Development
MCMCPA
Aug 11, 2017
Kincaid 1 Of 2 Sense Diagnostics
MCMCPA
Aug 10, 2017
This Device Looks Inside Your Brain
Cincinnati Public Radio
Jun 19, 2017
Sense Diagnostics Speeds Up Brain Trauma Detection
TechOhio
Jun 5, 2017
The Sensor Evaluation of Neurologic Status in Emergencies (SENSE) Device
American College of Emergency Physicians
May 2017
Cincinnati brain injury startup nabs $1.3M investment from Queen City Angels
Cincinnati Business Courier
Mar 16, 2017
2017 Health Care Heroes finalist: Dr. Opeolu Adeoye
Cincinnati Business Courier
Feb 23, 2017
Accelerant funds two start-ups up to $250K each
Dayton Daily News
Feb 09, 2017
'Time is brain': Startup Sense Diagnostics races to develop technology to save cognitive function
WCPO Cincinnati
Oct 15, 2016
In a hospital, he’s a mind reader
University of Cincinnati College of Medicine
May, 2016
Cincinnati Health Briefs for April 27
Cincinnati.com
Apr 26, 2016
Certain statements in this release are forward-looking and subject to risks and uncertainties. Actual results may differ materially depending on regulatory review, funding, and other factors.
NeuroHawk™ is an investigational device and is not yet cleared or approved by the U.S. Food and Drug Administration (FDA). It is not available for sale or clinical use in the United States. Information provided is for educational and investor purposes only.





















